About this trial

Obstructive sleep apnea (OSA) and Chronic Obstructive Pulmonary Disease (COPD) are highly prevalent chronic respiratory diseases in the Veteran population. OSA co-occurring with COPD, known as Overlap Syndrome (OVS), is a complex chronic medical condition associated with grave consequences. OVS is highly prevalent in Veterans. Veterans with OVS may be at increased risk for cognitive deficits, poor sleep quality as well as a reduced quality of life (QoL). The overall objective is to study the effects of positive airway pressure therapy on clinical outcomes in patients with OVS.

Eligibility criteria

Qualifiers

OSA with moderate-to-severe disease, AHI 20 per hour by in-lab polysomnography with concomitant moderate-severe COPD based on pulmonary function tests (PFTS) and with past significant history (>10 pack-years) of smoking

Male or female gender

Age greater than or equal to 60 years

Stable treatment regimen for COPD

Disqualifiers

Current or prior treatment with PAP or oral appliance

Central sleep apnea defined as central apnea index >5 per hour and comprising 50% of AHI

Known primary neuromuscular diseases

neurodegenerative disorders

Trial design

Treatments tested in this trial

  • Positive airway pressure
  • Conservative care (control arm)

Treatment groups

668 Participants
are divided into 2 treatment groups

Locations

1
John D. Dingell VA Medical Center, Detroit, MI48201-1916, DetroitMichigan, United States

Sponsors and collaborators

VA Office of Research and Development

Lead sponsor